SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-11-011277
Filing Date
2011-02-28
Accepted
2011-02-28 08:59:56
Documents
5
Period of Report
2011-02-25
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT v212892_8-k.htm 8-K 40947
2 PRESS RELEASE - NOVARTIS SETTLEMENT v212892_ex99-1.htm EX-99.1 9143
3 GRAPHIC pdl-logo.jpg GRAPHIC 24633
4 PRESS RELEASE - EPO DETERMINATION v212892_ex99-2.htm EX-99.2 9576
5 DIVIDENDS v212892_ex99-3.htm EX-99.3 11180
  Complete submission text file 0001144204-11-011277.txt   106520
Mailing Address 932 SOUTHWOOD BLVD INCLINE VILLAGE NV 89451
Business Address 932 SOUTHWOOD BLVD INCLINE VILLAGE NV 89451 775-832-8500
PDL BIOPHARMA, INC. (Filer) CIK: 0000882104 (see all company filings)

IRS No.: 943023969 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-19756 | Film No.: 11643331
SIC: 2836 Biological Products, (No Diagnostic Substances)